Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Methyl Alcohol SCHEMBL11582620 | 0.96 | TP53 (0.47) | — | |
| SCHEMBL605380 | 0.96 | — | — | |
| SCHEMBL11523353 | 0.92 | — | — | |
| Methylamine SCHEMBL18091752 | 0.89 | — | — | |
| Methyl Alcohol SCHEMBL11564408 | 0.89 | TP53 (0.47) | — | |
| Diethylamine SCHEMBL11582370 | 0.80 | TP53 (0.67) | — | |
| Diethylamine SCHEMBL28088004 | 0.80 | — | — | |
| SCHEMBL18610395 | 0.79 | — | — | |
| Tromethamine SCHEMBL1358336 | 0.76 | MEN1 (0.53) | — | |
| Diethylamine SCHEMBL538119 | 0.75 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109880840-B | In vivo biotinylation labeling system for recombinant protein escherichia coli | 福建农林大学 | 2023-01-10 | — | — | CN | disclosed |
| US-7470529-B2 | Chondroitin synthase and nucleic acid encoding the enzyme | SEIKAGAKU KOGYO KABUSHIKI KAISHA (JP) | 2008-12-30 | — | — | US | disclosed |
| EP-1514940-B1 | CHONDROITIN SYNTHETASE AND DNA CODING FOR THE ENZYME | SEIKAGAKU KOGYO CO LTD (JP) | 2008-11-19 | — | — | EP | disclosed |
| US-20080070996-A1 | CHONDROITIN SYNTHASE AND NUCLEIC ACID ENCODING THE ENZYME | SEIKAGAKU KOGYO KABUSHIKI KAISHA | 2008-03-20 | — | — | US | disclosed |
| EP-1514939-B1 | CHONDROITIN SYNTHETASE AND NUCLEIC ACID CODING FOR THE ENZYME | SEIKAGAKU KOGYO CO LTD (JP) | 2008-03-05 | — | — | EP | disclosed |
| US-7273729-B2 | Chondroitin synthase and DNA encoding the enzyme | SEIKAGAKU KOGYO KABUSHIKI KAISHA (JP) | 2007-09-25 | — | — | US | disclosed |
| US-7232676-B2 | Transfers a D-glucuronic acid residue to an N-acetyl-D-galactosamine residue when the N-acetyl-D-galactosamine residue is present at the non-reducing end of the chondroitin backbone, or transfers an N-acetyl-D-galactosamine residue to a D-glucuronic acid residue | SEIKAGAKU KOGYO KABUSHIKI KAISHA (JP) | 2007-06-19 | — | — | US | disclosed |
| US-20060057697-A1 | Chondroitin systhetase and nucleic acid coding for the enzyme | SEIKAGAKU CORPORATION (JP) | 2006-03-16 | — | — | US | disclosed |
| US-20060052335-A1 | Chondroitin synthetase and dna encoding the enzyme | SEIKAGAKU KOGYO KABUSHIKI KAISHA (JP) | 2006-03-09 | — | — | US | disclosed |
| EP-1514939-A1 | CHONDROITIN SYNTHETASE AND NUCLEIC ACID CODING FOR THE ENZYME | SEIKAGAKU CORPORATION (JP) | 2005-03-16 | — | — | EP | disclosed |
| EP-1514940-A1 | CHONDROITIN SYNTHETASE AND DNA CODING FOR THE ENZYME | SEIKAGAKU CORPORATION (JP) | 2005-03-16 | — | — | EP | disclosed |
| CN-1096292-A | The pyrrolidine derivatives as HIV protease inhibitors that replaces | BIO MEGA BOEHRINGER INGELHEIM (CA) | 1994-12-14 | — | — | CN | disclosed |